Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.
Daniel OehlerRaphael Romano BrunoUdo BoekenRalf WestenfeldPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
We demonstrate for the first time only moderate acceptance levels of COVID-19 vaccination in HTx recipients and candidates on the waiting list compared to general population, despite perceived high-risk for severe disease. Additionally, those supported by LVAD have even lower adherence. Efforts may need to be made to increase acceptance in this vulnerable as well as cost-intensive patient cohort.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- mental health
- newly diagnosed
- chronic kidney disease
- ejection fraction
- high intensity
- depressive symptoms
- peritoneal dialysis
- physical activity
- early onset
- respiratory syndrome coronavirus
- patient reported outcomes
- insulin resistance
- kidney transplantation
- drug induced
- patient reported